Team:UC Davis E/Opportunity
From 2012e.igem.org
(Difference between revisions)
(8 intermediate revisions not shown) | |||
Line 110: | Line 110: | ||
min-height:100%; /* real browsers */ | min-height:100%; /* real browsers */ | ||
} | } | ||
- | #content { z-index: 1; background-color: transparent; border: none; padding: 0; margin: 0; width: 100%; overflow: hidden; margin-top: -45px !important; | + | #content { z-index: 1; background-color: transparent; border: none; padding: 0; margin: 0; width: 100%; overflow: hidden; top:-3px; margin-top: -45px !important; |
height:auto !important; /* real browsers */ | height:auto !important; /* real browsers */ | ||
height:100%; /* IE6: treaded as min-height*/ | height:100%; /* IE6: treaded as min-height*/ | ||
Line 150: | Line 150: | ||
padding: 0; | padding: 0; | ||
padding-bottom: 10px; | padding-bottom: 10px; | ||
- | # background:url( | + | # background:url( ); |
# background-repeat: no-repeat; | # background-repeat: no-repeat; | ||
# background-attachment: fixed; | # background-attachment: fixed; | ||
Line 171: | Line 171: | ||
body { | body { | ||
background-color: rgba(255,255,255,1); | background-color: rgba(255,255,255,1); | ||
- | background-image: url(' | + | background-image: url(' '); |
background-size: 100%; | background-size: 100%; | ||
background-repeat: no-repeat; | background-repeat: no-repeat; | ||
Line 203: | Line 203: | ||
.topleft-menu:hover { | .topleft-menu:hover { | ||
color: white; | color: white; | ||
- | |||
} | } | ||
Line 233: | Line 232: | ||
.topleft-menu:hover a { | .topleft-menu:hover a { | ||
- | color: | + | color: ; |
} | } | ||
#newnavi { | #newnavi { | ||
position:relative; | position:relative; | ||
- | height: | + | height:42px; |
- | width: | + | width: 850px; |
margin-left: -2px; | margin-left: -2px; | ||
display:block; | display:block; | ||
background:transparent; | background:transparent; | ||
+ | |||
} | } | ||
#newnavi .newmenu { | #newnavi .newmenu { | ||
Line 250: | Line 250: | ||
list-style-type:none; | list-style-type:none; | ||
height:24px; | height:24px; | ||
+ | width: 107px; | ||
list-style-image:none; | list-style-image:none; | ||
- | background: # | + | background: #676767; |
} | } | ||
#newnavi .newmenu li { | #newnavi .newmenu li { | ||
float:right; | float:right; | ||
- | + | background: #676767; | |
- | + | text-align:center; | |
- | background: # | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
} | } | ||
#newnavi .newmenu .selected { | #newnavi .newmenu .selected { | ||
- | background: # | + | background: #05bcea; |
} | } | ||
#newnavi .newmenu li a { | #newnavi .newmenu li a { | ||
- | text-align:center; vertical-align:middle; width: | + | text-align:center; vertical-align:middle; width:121.5px; padding:5px 10px 5px 10px; display:block; color:#fff; text-decoration:none; font:14px arial, verdana, sans-serif; font-weight: bold; |
} | } | ||
#newnavi .newmenu li:hover a { | #newnavi .newmenu li:hover a { | ||
Line 277: | Line 269: | ||
} | } | ||
#newnavi .newmenu ul { | #newnavi .newmenu ul { | ||
- | position:absolute; left:-9999px; top:-9999px; list-style-type:none; list-style-image:none; margin:0px; border:0px; padding:0px; background: | + | position:absolute; left:-9999px; top:-9999px; list-style-type:none; list-style-image:none; margin:0px; border:0px; padding:0px; background: #05bcea; |
} | } | ||
#newnavi .newmenu li:hover { | #newnavi .newmenu li:hover { | ||
Line 283: | Line 275: | ||
} | } | ||
#newnavi .newmenu li:hover ul { | #newnavi .newmenu li:hover ul { | ||
- | left:0px; top: | + | left:0px; top:26px; background: #05bcea; width:150px; opacity:1.0 ; z-index:4; |
} | } | ||
#newnavi .newmenu li:hover ul li { | #newnavi .newmenu li:hover ul li { | ||
- | + | ||
- | + | background: #05bcea; | |
- | background: | + | |
} | } | ||
#newnavi .newmenu li:hover ul li a { | #newnavi .newmenu li:hover ul li a { | ||
- | text-align: | + | text-align:left; padding:5px 0px 5px 0px;display:block; font-size:12px; width:150px; text-indent:10px; color:#444; |
- | background-color: | + | background-color: #05bcea; text-decoration:none; |
} | } | ||
#newnavi .newmenu li:hover ul li a:hover { | #newnavi .newmenu li:hover ul li a:hover { | ||
- | + | background: #05bcea; color:#ffffff; width:150px; | |
} | } | ||
/* slide starts here */ | /* slide starts here */ | ||
Line 339: | Line 330: | ||
#myleftbox .smallbox | #myleftbox .smallbox | ||
{ | { | ||
- | width: | + | width:820px; |
float:left; | float:left; | ||
background-color:#bfbfbf; | background-color:#bfbfbf; | ||
Line 616: | Line 607: | ||
<div id="main-content"> | <div id="main-content"> | ||
- | + | <img src="https://static.igem.org/mediawiki/2012e/0/05/UCD_Logo.png" align="left"><br><br><br> | |
<div id="topmenubar" class="topleft-menu" > | <div id="topmenubar" class="topleft-menu" > | ||
<ul> | <ul> | ||
Line 631: | Line 622: | ||
</ul> | </ul> | ||
</div> | </div> | ||
- | + | <div id="newnavi"> | |
<ul class="newmenu"> | <ul class="newmenu"> | ||
- | + | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Attributions" title="Attributions">Contact</a> | |
+ | <ul> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Attributions ">Contact Us</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Attributions ">Attributions</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Attributions ">iGEM E</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
- | |||
- | |||
- | |||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Source_Data" title="Source Data">Media</a> | ||
+ | <ul> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Source_Data ">News Releases</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Source_Data ">Technical Papers</a></li> | ||
+ | </ul> | ||
</li> | </li> | ||
- | |||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Summary" title="Buisness">Our Business</a> | ||
+ | <ul> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Summary ">Business Model</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Summary">Business Plan</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Summary">Partners</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | |||
+ | <li class="selected"><a href="https://2012e.igem.org/Team:UC_Davis_E/Opportunity" title="Technology">Our Technology</a> | ||
+ | <ul> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Opportunity">Bioindustrial Enzyme</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Problem">Products</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Market">Process Advantage</a></li> | ||
+ | </ul> | ||
</li> | </li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Team" title="Company">Our Company</a> | ||
+ | <ul> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Team">Introduction</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Team">Vision</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Team">Management</a></li> | ||
+ | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E/Team">Advisory Board</a></li> | ||
- | + | </ul> | |
+ | </li> | ||
- | + | <li ><a href="https://2012e.igem.org/Team:UC_Davis_E" title="Home">Home</a></li> | |
- | <li ><a href="https://2012e.igem.org | + | |
- | + | ||
</ul> | </ul> | ||
</div> | </div> | ||
- | + | ||
- | <img src=" | + | <img src="https://static.igem.org/mediawiki/igem.org/0/06/UCD_Market_banner.jpg"> |
<div id="bodyContent"> | <div id="bodyContent"> | ||
Line 660: | Line 677: | ||
<!-- <div id="sponsorbox" style="width:220px; float:right;"> --> | <!-- <div id="sponsorbox" style="width:220px; float:right;"> --> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<div id="myleftbox"> | <div id="myleftbox"> | ||
Line 725: | Line 683: | ||
<!-- Safety content starts here --> | <!-- Safety content starts here --> | ||
- | <h1> | + | <h1> Overview </h1> |
<article> | <article> | ||
<br>A significant environmental problem facing the world entails the accumulation of plastic polymer waste products, both on land and offshore. The ecological, political, and economic repercussions of plastic accumulation have affected populations and industries alike in a significant manner, however, the technological development and profitability of investment in the business of plastic degradation has stunted the growth of such an institution. Our project aims to conduct an in depth analysis of the multitude of factors that would influence an industry centered around plastic degradation. Our collegiate iGEM team is currently engaged in producing an E. Coli that degrades PET plastic and goes further to break down byproducts, and we would similarly like to use this as a model for an economic and business analysis. Likewise, we also aim to generate a set of tools and guidelines that future iGEM teams can use to assess the realistic marketability of their project. We would like this toolkit to be applicable to a wide range of products under the field of synthetic biology, with the intent that teams and groups can take the product of laboratory based biological engineering and critically look at its real world application. In short, we wish to make successful commercial endeavors out of scientific academic work. | <br>A significant environmental problem facing the world entails the accumulation of plastic polymer waste products, both on land and offshore. The ecological, political, and economic repercussions of plastic accumulation have affected populations and industries alike in a significant manner, however, the technological development and profitability of investment in the business of plastic degradation has stunted the growth of such an institution. Our project aims to conduct an in depth analysis of the multitude of factors that would influence an industry centered around plastic degradation. Our collegiate iGEM team is currently engaged in producing an E. Coli that degrades PET plastic and goes further to break down byproducts, and we would similarly like to use this as a model for an economic and business analysis. Likewise, we also aim to generate a set of tools and guidelines that future iGEM teams can use to assess the realistic marketability of their project. We would like this toolkit to be applicable to a wide range of products under the field of synthetic biology, with the intent that teams and groups can take the product of laboratory based biological engineering and critically look at its real world application. In short, we wish to make successful commercial endeavors out of scientific academic work. |
Latest revision as of 01:12, 21 October 2012
Overview
A significant environmental problem facing the world entails the accumulation of plastic polymer waste products, both on land and offshore. The ecological, political, and economic repercussions of plastic accumulation have affected populations and industries alike in a significant manner, however, the technological development and profitability of investment in the business of plastic degradation has stunted the growth of such an institution. Our project aims to conduct an in depth analysis of the multitude of factors that would influence an industry centered around plastic degradation. Our collegiate iGEM team is currently engaged in producing an E. Coli that degrades PET plastic and goes further to break down byproducts, and we would similarly like to use this as a model for an economic and business analysis. Likewise, we also aim to generate a set of tools and guidelines that future iGEM teams can use to assess the realistic marketability of their project. We would like this toolkit to be applicable to a wide range of products under the field of synthetic biology, with the intent that teams and groups can take the product of laboratory based biological engineering and critically look at its real world application. In short, we wish to make successful commercial endeavors out of scientific academic work.